Abstract
Two large-scale pharmacogenomic studies were published recently in this journal. Genomic data are well correlated between studies; however, the measured drug response data are highly discordant. Although the source of inconsistencies remains uncertain, it has potential implications for using these outcome measures to assess gene-drug associations or select potential anticancer drugs on the basis of their reported results.
Original language | English |
---|---|
Pages (from-to) | 389–393 |
Journal | Nature |
Volume | 504 |
Issue number | 7480 |
DOIs | |
Publication status | Published - 19 Dec 2013 |